What is DA Davidson’s Forecast for Medifast Q1 Earnings?

Medifast, Inc. (NYSE:MED) – Equities research analysts at DA Davidson issued their Q1 2025 earnings per share (EPS) estimates for shares of Medifast in a report issued on Thursday, February 20th. DA Davidson analyst L. Weiser anticipates that the specialty retailer will post earnings of ($0.32) per share for the quarter. DA Davidson has a “Neutral” rating and a $16.50 price target on the stock. The consensus estimate for Medifast’s current full-year earnings is $0.51 per share. DA Davidson also issued estimates for Medifast’s FY2026 earnings at $0.50 EPS.

Medifast Stock Up 2.7 %

Shares of MED stock opened at $14.71 on Monday. Medifast has a 12 month low of $13.57 and a 12 month high of $42.68. The firm has a market cap of $160.93 million, a PE ratio of 81.74 and a beta of 1.14. The stock has a 50 day moving average of $16.16 and a 200-day moving average of $17.89.

Medifast (NYSE:MED) last posted its earnings results on Tuesday, February 18th. The specialty retailer reported $0.10 earnings per share for the quarter, topping the consensus estimate of ($0.16) by $0.26. Medifast had a return on equity of 10.64% and a net margin of 0.35%. The firm had revenue of $119.00 million during the quarter, compared to analyst estimates of $114.25 million.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the business. JPMorgan Chase & Co. lifted its holdings in shares of Medifast by 156.1% during the third quarter. JPMorgan Chase & Co. now owns 57,455 shares of the specialty retailer’s stock worth $1,100,000 after buying an additional 35,017 shares during the last quarter. Centiva Capital LP lifted its holdings in shares of Medifast by 6.3% during the third quarter. Centiva Capital LP now owns 15,238 shares of the specialty retailer’s stock worth $292,000 after buying an additional 898 shares during the last quarter. Nisa Investment Advisors LLC lifted its holdings in shares of Medifast by 2,308.8% during the fourth quarter. Nisa Investment Advisors LLC now owns 11,442 shares of the specialty retailer’s stock worth $202,000 after buying an additional 10,967 shares during the last quarter. Quarry LP lifted its holdings in shares of Medifast by 148.6% during the third quarter. Quarry LP now owns 6,629 shares of the specialty retailer’s stock worth $127,000 after buying an additional 3,962 shares during the last quarter. Finally, FMR LLC lifted its holdings in shares of Medifast by 44.6% during the third quarter. FMR LLC now owns 30,786 shares of the specialty retailer’s stock worth $589,000 after buying an additional 9,499 shares during the last quarter. 95.51% of the stock is currently owned by institutional investors and hedge funds.

Medifast Company Profile

Medifast, Inc, through its subsidiaries, engages in the manufacture and sale of weight loss, weight management, and healthy living products in the United States and the Asia-Pacific. It offers bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brand names.